Identification of TRA‐1‐60‐positive cells as a potent refractory population in follicular lymphomas

Despite receiving rituximab‐combined chemotherapy, follicular lymphoma (FL) patients often suffer tumor recurrence and understand that the cause of relapse in FL would thus significantly ameliorate the tumor therapeutics. In the present study, we show that TRA‐1‐60‐expressing cells are a unique popu...

Descripción completa

Detalles Bibliográficos
Autores principales: Takata, Katsuyoshi, Saito, Ken, Maruyama, Satoshi, Miyata‐Takata, Tomoko, Iioka, Hidekazu, Okuda, Shujiro, Ling, Yiwei, Karube, Kennosuke, Miki, Yukari, Maeda, Yoshinobu, Yoshino, Tadashi, Steidl, Christian, Kondo, Eisaku
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6317956/
https://www.ncbi.nlm.nih.gov/pubmed/30417470
http://dx.doi.org/10.1111/cas.13870

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6317956/
https://www.ncbi.nlm.nih.gov/pubmed/30417470
http://dx.doi.org/10.1111/cas.13870

Ejemplares similares